A womb with a view

As mouse models of human disease become more important in drug discovery,
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
SALT LAKE CITY, Utah—As mouse models of human disease become more important in drug discovery, scientists are looking for ways to systematically analyze morphological changes triggered by mutations or the knock-out of every gene in the mouse genome. To facilitate this, researchers at the University of Utah and San Antonio's University of Texas Health Science Center recently developed a high-throughput virtual histology platform. They describe their system in PLoS Genetics.
Continue reading below...
Illustration of diverse healthcare professionals interacting with digital medical data and health records on virtual screens.
WebinarsAccelerating rare disease clinical trials
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
Read More
Using x-ray microscopic computed tomography (microCT) on osmium tetroxide-stained mouse embryos, the researchers could identify morphological features down to 8-μm resolution. The platform therefore offers comparable but less expensive results than the more traditional magnetic resonance microscopy. And because staining increases with lipid content, they were able to observe large differences in tissue densities.
The researchers used the platform to study a large number of mutant and wild type mouse embryos, and suggested that the platform could perform semi- or fully automated high-throughput screening of both gross and subtle morphological changes when used at 27- μm resolution. According to Michael Beeuwsaert, CEO of Numira Biosciences, which holds the platform's commercial license: "The datasets generated by virtual histology will facilitate the use of computational methods for organ patterning analysis."

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
A 3D rendering of red and yellow protein molecules floating in a fluid-like environment.
Discover approaches that shorten the path from DNA constructs to purified, functional proteins.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue